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1. Introduction 
Studies with human fibroblasts have defined a 
receptor-mediated pathway by which cells take up 
and degrade low density lipoprotein (LDL), the major 
cholesterol(ester)-transport pr tein in human plasma 
[ 1 ]. Internalization of the particle is followed after 
recognition by a specific receptor. These receptors are 
clustered in coated regions of the cell membrane, 
so-called coated pits. Upon LDL binding the coated 
pits invaginate and form coated endocytotic vesicles 
which fuse subsequently with lysosomes. The protein 
moiety and the cholesterol esters are then degraded 
by the action of cathepsins and acid cholesterol ester- 
ase, respectively. Although the different steps involved 
in receptor-mediated endocytosis have been described, 
the molecular mechanisms involved in the process are 
largely unknown. Peritoneal macrophages possess a
binding site for acetylated LDL which is distinct from 
the native LDL receptor [2]. On macrophages this 
binding site is coupled to a very active internalization 
and degradation process. This property facilitates the 
study of the molecular mechanism of the uptake and 
degradation pathway. This is also illustrated by the 
finding that after injection of lzSI-labeled acetyl-LDL 
into rats, these particles are rapidly cleared from the 
circulation (<.3 rain). The radioactivity is subse- 
quently merely recovered in the non-parenchymal 
liver cells (unpublished). This study describes the in 
vitro binding of both native and acetylated LDL to 
freshly isolated non-parenchymal liver cells. Binding 
of acetylated LDL to these cells is only twice as high 
as the binding of native LDL but the degradation is 
increased 30-50-fold after acetylation of the LDL. 
The degradation of acetylated LDL is inhibited by 
chloroquine and NH4C1, indicating a lysosomal pro- 
cess. Mg-EDTA at 2 mM inhibits the degradation of 
acetyl-LDL by 50% and trifluoperazine (50/IM), an 
inhibitor of calmodulin [3,4], blocks the degradation 
completely. The rate of association of acetyl-LDL 
with non-parenchymal ce ls is only slightly inhibited 
by trifluoperazine. It is concluded that the main 
action of trifluoperazine is exerted on the route of 
acetyl-LDL to the lysosomes after the initial binding 
process. The data are consistent with a role of cal- 
modulin in the receptor-mediated endocytotic pro- 
cess although it cannot be excluded that trifluoperazine 
interacts with another still unknown target. 
2. Materials and methods 
2.1. Isolation, modification and labeling o f  LDL 
Human LDL was isolated exactly as in [5]. The 
density range was 1.019-1.063. LDL was acetylated 
with repeated additions of acetic anhydride as in [6]. 
In short, 1 ml LDL (at 2-10 mg protein/ml)in 
0.15 M NaC1, I mM EDTA and 8 mM phosphate 
buffer (pH 7.5) was added to 1 ml of a saturated 
solution of sodium acetate with continuous tirring in 
an ice-water bath. Next, acetic anhydride was added 
in multiple small aliquots (2/ll) over 1 h. After the 
addition of a total mass of acetic anhydride qual to 
1.5-times the mass of protein used, the mixture was 
stirred for an additional 30 rain. The solution was 
then dialyzed overnight at 6°C against buffer contain- 
ing 0.15 M NaC1, 1 mM EDTA and 8 mM phosphate 
buffer (pH 7.5). Both LDL and acetyl-LDL were 
iodinated at pH 10 by the IC1 method [7], as modi- 
fied for lipoproteins [8]. Free I-  was removed by 
Sephadex G-50 filtration. The iodine:protein ratio 
was between 0.6-0.8 atoms/mol for both LDL and 
acetyl-LDL. Of the radioactivity in the preparation, 
3-4% was flee, 3-5% was present in phospholipids 
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and 92-94% was protein-bound. The only apoprotein 
present in LDL is apolipoprotein B as determined on 
SDS-polyacrylamide el ctrophoresis [ 10]. 
2.2. Isolation of liver cells 
Isolation of rat non-parenchymal liver cells was 
performed by differential centrifugation (method 2
in [9]). 
2.3. Lipoprotein binding, uptake and degradation 
Incubations of freshly isolated liver cells with the 
indicated amounts of lipoproteins and cells were per- 
formed in Ham's F-10 medium (modified), containing 
5% (v/v) human lipoprotein-deficient serum (LPDS; 
final protein 2.5 mg/ml). The incubations were car- 
ried out either in plastic Eppendorf tubes in t ml 
total vol. or in 25 ml Erlenmeyer flasks (siliconized) 
stoppered with rubber caps with a total incubation 
volume and time as indicated in the figure legends. At 
the indicated times 1 ml samples were withdrawn and 
the cells were centrifuged in an Eppendorf centrifuge 
for 2 min at 3000 rev./min. The pellets were sus- 
pended in 1 ml medium containing 50 mM Tris-HC1 
(pH 7.4), 0.15 M NaCl and 2 mg bovine serum albu- 
min, incubated for 5 min at 4°C and centrifuged 
again. This washing procedure was repeated twice. 
The last washing was performed with 0.15 M NaCI 
only to enable a reliable protein determination. The 
cell-associated radioactivity and 0.5 ml of the differ- 
ent supernatants were counted in a LKB-Wallace 
ultrogamma counter. The radioactivity in the last 
supernatant was <5% of the cell-associated radioactiv- 
ity. Degradation of the lipoproteins was measured as 
in [11]. To 0.5 ml of the first supernatant, 0.2 ml 
35% trichloroacetic a id was added followed by incu- 
bation for 15 rain at 37°C; subsequently the mixture 
was centrifuged for 2 min at 15 000 rev./min. To 
0.5 ml of the supernatants 5/al 40% KI and 25/al 30% 
H202 were added. After 5 min at room temperature 
0.8 ml CHC13 was added and the mixture was shaken 
for another 5 min. After centrifugation for 2 min at 
15 000 rev./min, 0.4 ml of the aqueous phase (con- 
taining iodinated amino acids and small peptides) and 
0.5 ml of the CHCI~ phase (containing I2 formed 
from I- by oxidation with H202) was counted. This 
sample was corrected for quenching by CHCI3. In the 
corresponding blanks the lipoproteins were incubated 
in the absence of cells. Further additions are indi- 
cated in the figure legends. 
The viability of the cells was >95%. The viability 
was also checked after addition of chloroquine or tri- 
fluoperazine. It was found that high chloroquine con- 
centrations (>100 taM) lead to a lower viability of the 
cells especial at the longer incubation times. With the 
concentrations u ed in this paper no decrease in cell 
viability was observed. 
2.4. Reagents 
Collagenase (type I) was obtained from Sigma. Tri- 
fluoperazine was supplied by Smith, Kline and 
French Labs. 
3. Results 
Fig.1 shows the time course of the interaction of 
lzsI-labeled LDL and 12SI-labeled acetylated LDL 
with the freshly isolated non-parenchymal ce ls. The 
amount of cell-associated lipoprotein rapidly increases 
and levels off at the longer incubation times. With rat 
lipoproteins, the amount of cell-associated radioactiv- 
ity remained constant from 0.5-3 h incubation [10]. 
Such a steady-state level is not readily observed with 
human LDL or acetyl-LDL, although in some experi- 
ments the increase in cell-associated radioactivity from 
2-3 h incubation was found to be low. The appear- 
ance of acid-soluble radioactivity in the water phase 
follows a completely different ime dependency than 
the amount of cell-associated radioactivity. With 
acetyl-LDL a lag phase is evident (l 0-30 min) before 
the degradation reaches aconstant rate (from 1-3 h). 
This degradation is completely blocked by chloro- 
quine (100/aM, fig.2) or NH4C1 (10 mM, not shown). 
Both unrelated compounds inhibit the lyosomat 
pathway of protein degradation [ 12]. So it can be 
concluded that acetyl-LDL follows an endocytotic 
route which involves the lysosomal compartment. 
Fig.2 also indicates that a similar inhibition of acetyl- 
LDL degradation occurs if 100/aM trifluoperazine is 
present. With 25/aM trifluoperazine intermediate 
inhibition is obtained. Fig.2 indicates that trifluo- 
perazine also influences the initial phase of the inter- 
action of acetyl-LDL with the cells. At shorter incu- 
bation times a lower anaount of radioactivity is 
cell-associated than in the control incubation. How- 
ever, this is not observed at prolonged incubation 
times, probably because the initial slight interaction 
of trifluoperazine with the binding of acetyl-LDL is 
compensated by the accumulation of acetyl-LDL due 
to an impaired egradation. 
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Fig.l .  Time course of  the cell association and degradation of  LDL and acetyl-LDL by isolated non-parenchymal liver cells. The 
cells were incubated with 10.0 ~zg LDL/ml ( I ,a) or 10.1 #g acetyl-LDL/ml (A,a). At the indicated time samples were withdrawn 
and the amount  of  cell-associated radioactivity (after 3 washings, left) as well as the radioactivity present in the acid-soluble water 
phase were determined (right). Both cell association and degradation are expressed as ng apolipoprotein/mg cell protein. 
Trifluoperazine has been considered as a specific 
inhibitor of calmodulin, a protein which mediates the 
action of Ca 2÷ upon a number of cellular processes 
[4,13]. In [14] coated vesicles of brain were 7-fold 
enriched with calmodulin. The presence of calmodu- 
lin in the coated vesicles hould be rationalized by a 
function in the endocytotic process. Fig.3 shows that 
the degradation of acetyl-LDL by non-parenchymal 
cells is hardly influenced by changes in the extracel- 
lular [Ca2÷]. In the presence of 2 mM Mg-EDTA, 
however, the degradation is ~50% of that measured 
in the absence of Mg-EDTA. From fig.3 it is also clear 
that this effect is not the consequence of the involve- 
ment of Ca 2÷ in the acetyl-LDL binding process, but 
apparently occurs at a step between binding and 
degradation. Fig.4 shows that the effective inhibitory 
concentration of trifluoperazine upon acetyl-LDL 
degradation is low. At 50/aM, trifluoperazine exhibits 
Table 1 
Effect of trifluoperazine upon the in vitro degradation of  
human iodine-labeled acetylated low density apolipoprotein 
by non-parenchymal cell homogenates 
Degradation (ng apolipo- 
protein,  h -1 . mg 
cell protein-I ) 
Acetyl-LDL 1832 -+ 57 
+ 100 ~M trifluoperazine 1983 -+ 50 
The cells were homogenized by sonificating twice for 30 s at 
21 kHz in a MSE ultrasonic desintegrator at 0°C. Incubations 
were carried out for 60 min at 37°C in acetate buffer (pH 4.2), 
4 mM dithiothreitol and 10.8 tag/m112sI-tabeled acetylated- 
LDL. The reaction was stopped by addition of 10% trichloro- 
acetic acid and the acid-soluble water phase was obtained as 
indicated in section 2. For further details of the in vitro deg- 
radation measurements see [15 ]. The values are the mean -+ 
SEM for 3 determinations 
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Fig.2. Effect of chloroquine and trifluoperazine upon the time course of the cell association and degradation of acetyl-LDL. The 
cells were incubated with 10.2 ug acetyl-LDL/ml in the absence (A,A) or presence of: 100 uM chloroquine (v,v); 100 pM trifluo- 
perazine (e,e); or 25 ~M trifluoperazine (~,o). Both cell association (left) and degradation (right) are expressed as ng apolipopro- 
tein/mg cell protein. 
already a nearly complete inh ib i t ion and the half- 
maximal  inh ib i tory  concentrat ion  is ~20 #M. To ver- 
ify whether  tr i f luoperazine acts directly upon lyso- 
somal enzymes we studied the effect of  100/~M 
tr i f luoperazine upon the acety l -LDL degradation in a 
NPC association 
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NPC degradation 
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a 
cell-free system at an opt imal  degradation pH of  4.2 
(table 1). No inh ib i tory  effect of  tr i f luoperazine on 
the degradat ion by non-parenchymal  cell homoge- 
nates was not iced.  
4. Discussion 
Non-parenchymal  liver cells possess high aff inity 
sites which can b ind rat LDL and HDL [16]. The 
Fig.3. The effect of Mg-EDTA and Ca 2+ upon the cell-associa- 
tion and degradation of acetyl-LDL by isolated non-paren- 
chymal cells. The cells were incubated 2 h with 5.5 ~g acetyl- 
LDL]ml with the different indicated [Mg-EDTA] or [Ca2+]. 
For the cells incubated with Mg-EDTA the last 2 washings 
before incubation, were also performed in the presence of 
2 mM Mg-EDTA. Tim results were obtained with 3 different 
acetyl-LDL and cell preparations and are given as % of tire 
association or degradation at0.3 mM Ca ~+ + SEM. The 100% 
value for the cell assocation is 470 ng acetyl-LDL/mg cell 
protein and for the degradation 732 ng acetyl-LDL/mg cell 
protein. 
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Fig.4. The effect of  increasing trifluoperazine concentrations upon the cell association and degradation of  acetyl-LDL by isolated 
non-parenchymal liver cells. The cells were incubated for 2 h with 10.3 ~g acetyl-LDL/ml in the presence of  the indicated amount  
of  trifluoperazine. The results were obtained with 3 different acetyl-LDL and cell preparations and are given as % of the associa- 
tion or degradation i  the absence of  trifluoperazine ±SEM. The 100% value for the cell association is 690 ng acetyl-LDL/mg cell 
protein and for the degradation 844 ng acetyl-LDL/mg cell protein. 
binding of rat LDL, HDL and also VLDL-remnants 
occurred at the same receptor. This receptor recog- 
nizes all these rat lipoproteins with a highest apparent 
affinity for VLDL-remnants [10]. Here we show that 
non-parenchymal ce ls bind and metabolize, in addi- 
tion to the rat lipoproteins, both human LDL and 
acetyl-LDL. Although the cell-association f acetyl- 
LDL is only twice as high as for native LDL, the 
acetylation of native LDL increases the degradation 
30-50-times. This high increase in degradation can be 
expected from macrophage-like c ll types [2]. The 
degradation of acetyl-LDL by freshly isolated non- 
parenchymal liver cells is completely blocked by 
chloroquine (fig.2) or NH4C1 (not shown). The 
incomplete inhibition during the first hour of incuba- 
tion can be explained by the fact that the cells were 
not preincubated with these lysosomotropic agents. 
Together with the clear lag phase before degradation 
starts, this is strong evidence that the handling of 
acetyl-LDL follows the endocytotic route for recep- 
tor-mediated uptake, i.e., binding to a high affinity 
receptor (properties of this receptor will be reported 
elsewhere), uptake in endocytotic vesicles and degra- 
dation inside the lysosomes. These data show further 
that trifluoperazine, an inhibitor of calmodulin [34], 
inhibits the degradation of acetyl-LDL. The acetyl- 
LDL degradation is highly sensitive to trifluoperazine, 
with a half-maximal inhibition at 20 #M. Similar con- 
centrations are reported to inhibit other calmodulin- 
mediated cellular processes [ 17,18]. Although this 
inhibition is consistent with a role of calmodulin in 
the endocytotic process the reported finding cannot 
be considered as conclusive. In [19] it was reported 
that the inhibitory action of trifluoperazine upon the 
effect of a-adrenergic agonists is due to a blockade of 
the binding of the a-adrenergic agonists to their 
receptor which is not mediated by calmodulin. For 
this reason, besides its action upon the degradation, 
we also investigated the effect of trifluoperazine upon 
the rate of cell-association f acetyl-LDL. It is shown 
that trifluoperazine indeed interacts with the initial 
binding (as does chloroquine), however, this does not 
explain the complete inhibition of the degradation 
of acetyl-LDL by trifluoperazine. Although a small 
inhibition of the cell-association ccurs (at shorter 
incubation time), this inhibition is not observed at 
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prolonged incubation time probably because it is 
compensated by the main action of trifluoperazine, 
i.e., the blockade of the route to the lysosomes of 
acetyl-LDL, after the initial binding process. The 
action of trifluoperazine is probably not at the lyso- 
somes themselves because the in vitro degradation of 
acetyl-LDL by cell homogenates at an acid pH is not 
inhibited by trifluoperazine. Further evidence that 
calmodulin is involved in the intracellular handling 
process of acetyl-LDL can also be deducted from the 
experiments in which the effect of Mg-EDTA and 
Ca z+ was tested. In contrast with most other ligand- 
receptor interactions [13,20], the association of 
acetyl-LDL with the cells was not Ca z+ or Mg-EDTA- 
dependent. This makes it possible to separate the cell- 
association process from the subsequent cellular 
handling and the data indicate that, in the presence of 
Mg-EDTA the degradation of acetyl-LDL is inhibited 
by ~50%. A complete inhibition was, however, not 
observed probably because xtracellular Mg-EDTA is 
not able to deplete intracellular Ca 2+ completely. In 
conclusion it can be stated that, in addition to the 
data in [14] where calmodulin was shown to be 
highly enriched in endocytotic vesicles, our data can 
be considered as evidence that calmodulin, or another 
still unknown target of trifluoperazine, is involved in 
the receptor-mediated endocytotic process. 
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